# UPTRAVI

NDC: 66215-718
Generic name: Selexipag
Labeler / Manufacturer: Actelion Pharmaceuticals US, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20210729

FDA application: NDA214275

## Active ingredients

- SELEXIPAG: 1800 ug/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66215-718"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66215-718
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7a23b87-f892-4e2c-8e2e-ebf841220f90